Skip to main content
. 2023 Oct 10;93(1):79–88. doi: 10.1007/s00280-023-04591-y

Fig. 4.

Fig. 4

Olaparib plasma concentration–time profiles (mean ± SD) in the rats which received olaparib (IIIOLA) and metformin + olaparib (IMET+OLA)